The U.S. Food and Drug Administration said Thursday it can’t regulate CBD supplements because there isn’t enough evidence on their safety. The agency also called on Congress to create new rules for what has become a burgeoning industry.
“The use of CBD raises various safety concerns, especially with long-term use,” FDA Deputy Commissioner Dr. Janet Woodcock said in a statement. “Studies have shown the potential for harm to the liver, interactions with certain medications and possible harm to the male reproductive system. CBD exposure is also concerning when it comes to certain vulnerable populations such as children and those who are pregnant.”
